The ablation devices market size has grown strongly in recent years. It will grow from $9.25 billion in 2025 to $10.12 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing prevalence of cancer treatment procedures, rising adoption of ablation in cardiac arrhythmia management, growth in hospital installation of radiofrequency and laser ablation systems, expanding clinical acceptance of minimally invasive therapy alternatives, increasing usage of cryoablation and microwave ablation in specialty care.
The ablation devices market size is expected to see strong growth in the next few years. It will grow to $14.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for precision targeted tissue ablation technologies, growing adoption of robotic and automatic ablation systems, expansion of ablation applications across multiple therapeutic areas, increasing investment in outpatient and ambulatory surgical infrastructure, rising preference for minimally invasive procedures with faster recovery. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures across oncology and cardiology, rising utilization of radiofrequency and microwave ablation systems for targeted tissue destruction, growing preference for cryoablation and hydrothermal ablation in specialized clinical applications, expanding clinical use of laser and ultrasound ablation devices for precision therapeutic outcomes, increasing deployment of ablation technologies in ambulatory and outpatient surgical settings.
The rising incidence of cancer is anticipated to drive the growth of the microwave ablation devices market in the coming years. Cancer is a condition characterized by the uncontrolled growth of abnormal cells that can spread to other parts of the body. The increase in cancer cases is largely attributed to longer life expectancy, which raises the risk of age-related diseases such as cancer. Microwave ablation devices are used in cancer treatment by emitting electromagnetic waves that generate heat to destroy tumor cells. This targeted and minimally invasive technique helps preserve surrounding healthy tissue and supports faster patient recovery. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 35 million new cancer cases were projected by 2050, representing a 77% increase compared to the estimated 20 million cases reported in 2022. As a result, the growing number of cancer cases is fueling the expansion of the microwave ablation devices market.
Major companies operating in the microwave ablation devices market are emphasizing the development of advanced products with regulatory approvals, such as high-precision microwave ablation systems, to enhance patient outcomes in minimally invasive cancer treatments. A high-precision microwave ablation system is an advanced medical device that uses focused microwave energy to accurately destroy tumor tissue. It delivers controlled heat to targeted areas while minimizing damage to adjacent healthy structures, thereby improving safety and treatment effectiveness. For instance, in January 2024, Hygea Medical Technology Co. Ltd., a China-based medical device manufacturer, received approval from the Food and Drug Administration (FDA) for its EXCEED microwave treatment system and EXACT series microwave ablation probes. This approval followed prior clearance from China’s National Medical Products Administration (NMPA) and was obtained through an expedited review process. The FDA clearance confirms the safety, performance, and quality of Hygea’s products for the treatment of various solid tumors in soft tissues, marking a key milestone in the company’s international expansion, particularly in the U.S. microwave ablation market. This system complements existing cancer therapies by providing a high-precision, minimally invasive thermal ablation solution.
In July 2024, Creo Medical Group plc, a UK-based manufacturer of flexible microwave ablation devices, entered into a partnership with Intuitive Surgical Inc. to advance minimally invasive lung cancer treatment. The collaboration is intended to integrate Creo’s MicroBlate Flex and Kamaptive technologies with Intuitive’s Ion Endoluminal System, supporting expanded clinical studies and improving precision in lung cancer diagnosis and ablation across the UK and Europe. Intuitive Surgical Inc. is a US-based provider of minimally invasive care and a pioneer in robotic surgery.
Major companies operating in the ablation devices market are Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, AngioDynamics Inc, CONMED Corporation, Olympus Corporation, Smith & Nephew plc, AtriCure Inc, Stryker Corporation, Biotronik SE & Co KG, BTG plc, Terumo Corporation, Varian Medical Systems Inc, Hologic Inc, Accuray Inc, Bard Inc, Elekta AB, Misonix Inc, Japan Lifeline Co Ltd.
North America was the largest region in the ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ablation devices market by increasing import and component acquisition costs for electronic controllers, semiconductor modules, optical assemblies, and energy-delivery components used in laser, radiofrequency, microwave, ultrasound, cryoablation, and electrosurgical systems. Higher duties particularly affect regions relying on cross-border sourcing from Asia-Pacific and Europe, influencing procurement budgets for hospitals, clinics, and ambulatory surgical centers. However, tariffs are also encouraging localized manufacturing, regional supplier development, and cost-optimized product engineering, which support supply-chain resilience and stimulate innovation in next-generation ablation technologies.
The ablation devices market research report is one of a series of new reports that provides ablation devices market statistics, including ablation devices industry global market size, regional shares, competitors with a ablation devices market share, detailed ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the ablation devices industry. This ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ablation devices are medical instruments used to eliminate abnormal tissue growths or dysfunctional cells, such as tumors or cardiac arrhythmias, employing various energy sources such as heat, cold, or radiofrequency. These devices play a crucial role in minimally invasive procedures aimed at treating conditions ranging from cancer to heart rhythm disorders.
The primary types of ablation devices include laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators, and cryoablators. Laser ablators utilize laser energy for precise material removal or modification, commonly applied in industrial settings. The technology encompasses various methods such as radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others, often incorporating automated and robotic functionalities. These devices are utilized by diverse end-users including hospitals, clinics, ambulatory surgical centers, and others.
The ablation devices market consists of sales of medical devices such as irreversible electroporation (IRE) ablators, photodynamic therapy (PDT) ablators, high-intensity focused ultrasound (HIFU) ablators, chemical ablators, and mechanical ablators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ablation devices market size is expected to see strong growth in the next few years. It will grow to $14.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for precision targeted tissue ablation technologies, growing adoption of robotic and automatic ablation systems, expansion of ablation applications across multiple therapeutic areas, increasing investment in outpatient and ambulatory surgical infrastructure, rising preference for minimally invasive procedures with faster recovery. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures across oncology and cardiology, rising utilization of radiofrequency and microwave ablation systems for targeted tissue destruction, growing preference for cryoablation and hydrothermal ablation in specialized clinical applications, expanding clinical use of laser and ultrasound ablation devices for precision therapeutic outcomes, increasing deployment of ablation technologies in ambulatory and outpatient surgical settings.
The rising incidence of cancer is anticipated to drive the growth of the microwave ablation devices market in the coming years. Cancer is a condition characterized by the uncontrolled growth of abnormal cells that can spread to other parts of the body. The increase in cancer cases is largely attributed to longer life expectancy, which raises the risk of age-related diseases such as cancer. Microwave ablation devices are used in cancer treatment by emitting electromagnetic waves that generate heat to destroy tumor cells. This targeted and minimally invasive technique helps preserve surrounding healthy tissue and supports faster patient recovery. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 35 million new cancer cases were projected by 2050, representing a 77% increase compared to the estimated 20 million cases reported in 2022. As a result, the growing number of cancer cases is fueling the expansion of the microwave ablation devices market.
Major companies operating in the microwave ablation devices market are emphasizing the development of advanced products with regulatory approvals, such as high-precision microwave ablation systems, to enhance patient outcomes in minimally invasive cancer treatments. A high-precision microwave ablation system is an advanced medical device that uses focused microwave energy to accurately destroy tumor tissue. It delivers controlled heat to targeted areas while minimizing damage to adjacent healthy structures, thereby improving safety and treatment effectiveness. For instance, in January 2024, Hygea Medical Technology Co. Ltd., a China-based medical device manufacturer, received approval from the Food and Drug Administration (FDA) for its EXCEED microwave treatment system and EXACT series microwave ablation probes. This approval followed prior clearance from China’s National Medical Products Administration (NMPA) and was obtained through an expedited review process. The FDA clearance confirms the safety, performance, and quality of Hygea’s products for the treatment of various solid tumors in soft tissues, marking a key milestone in the company’s international expansion, particularly in the U.S. microwave ablation market. This system complements existing cancer therapies by providing a high-precision, minimally invasive thermal ablation solution.
In July 2024, Creo Medical Group plc, a UK-based manufacturer of flexible microwave ablation devices, entered into a partnership with Intuitive Surgical Inc. to advance minimally invasive lung cancer treatment. The collaboration is intended to integrate Creo’s MicroBlate Flex and Kamaptive technologies with Intuitive’s Ion Endoluminal System, supporting expanded clinical studies and improving precision in lung cancer diagnosis and ablation across the UK and Europe. Intuitive Surgical Inc. is a US-based provider of minimally invasive care and a pioneer in robotic surgery.
Major companies operating in the ablation devices market are Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, AngioDynamics Inc, CONMED Corporation, Olympus Corporation, Smith & Nephew plc, AtriCure Inc, Stryker Corporation, Biotronik SE & Co KG, BTG plc, Terumo Corporation, Varian Medical Systems Inc, Hologic Inc, Accuray Inc, Bard Inc, Elekta AB, Misonix Inc, Japan Lifeline Co Ltd.
North America was the largest region in the ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ablation devices market by increasing import and component acquisition costs for electronic controllers, semiconductor modules, optical assemblies, and energy-delivery components used in laser, radiofrequency, microwave, ultrasound, cryoablation, and electrosurgical systems. Higher duties particularly affect regions relying on cross-border sourcing from Asia-Pacific and Europe, influencing procurement budgets for hospitals, clinics, and ambulatory surgical centers. However, tariffs are also encouraging localized manufacturing, regional supplier development, and cost-optimized product engineering, which support supply-chain resilience and stimulate innovation in next-generation ablation technologies.
The ablation devices market research report is one of a series of new reports that provides ablation devices market statistics, including ablation devices industry global market size, regional shares, competitors with a ablation devices market share, detailed ablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the ablation devices industry. This ablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ablation devices are medical instruments used to eliminate abnormal tissue growths or dysfunctional cells, such as tumors or cardiac arrhythmias, employing various energy sources such as heat, cold, or radiofrequency. These devices play a crucial role in minimally invasive procedures aimed at treating conditions ranging from cancer to heart rhythm disorders.
The primary types of ablation devices include laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators, and cryoablators. Laser ablators utilize laser energy for precise material removal or modification, commonly applied in industrial settings. The technology encompasses various methods such as radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others, often incorporating automated and robotic functionalities. These devices are utilized by diverse end-users including hospitals, clinics, ambulatory surgical centers, and others.
The ablation devices market consists of sales of medical devices such as irreversible electroporation (IRE) ablators, photodynamic therapy (PDT) ablators, high-intensity focused ultrasound (HIFU) ablators, chemical ablators, and mechanical ablators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ablation Devices Market Characteristics
3. Ablation Devices Market Supply Chain Analysis
4. Global Ablation Devices Market Trends and Strategies
5. Ablation Devices Market Analysis of End Use Industries
7. Global Ablation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ablation Devices Total Addressable Market (TAM) Analysis for the Market
9. Ablation Devices Market Segmentation
10. Ablation Devices Market Regional and Country Analysis
11. Asia-Pacific Ablation Devices Market
12. China Ablation Devices Market
13. India Ablation Devices Market
14. Japan Ablation Devices Market
15. Australia Ablation Devices Market
16. Indonesia Ablation Devices Market
17. South Korea Ablation Devices Market
18. Taiwan Ablation Devices Market
19. South East Asia Ablation Devices Market
20. Western Europe Ablation Devices Market
21. UK Ablation Devices Market
22. Germany Ablation Devices Market
23. France Ablation Devices Market
24. Italy Ablation Devices Market
25. Spain Ablation Devices Market
26. Eastern Europe Ablation Devices Market
27. Russia Ablation Devices Market
28. North America Ablation Devices Market
29. USA Ablation Devices Market
30. Canada Ablation Devices Market
31. South America Ablation Devices Market
32. Brazil Ablation Devices Market
33. Middle East Ablation Devices Market
34. Africa Ablation Devices Market
36. Ablation Devices Market Competitive Landscape and Company Profiles
37. Ablation Devices Market Other Major and Innovative Companies
40. Ablation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ablation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ablation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ablation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Laser Ablators; Radiofrequency Ablators; Microwave Ablators; Ultrasound Ablators; Electric Ablators; Hydrothermal Ablators; Cryoablators2) By Technology Type: Radiofrequency Ablation; Microwave Ablation; Cryoablation; High-Intensity Focused Ultrasound; Laser Interstitial Thermal Ablation; Other Technology Types
3) By Function: Automatic; Robotic
4) By End-Users: Hospitals And Clinics; Ambulatory Surgical Centers; Others End-Users
Subsegments:
1) By Laser Ablators: Diode Laser Systems; CO2 Laser Systems; Nd-YAG Laser Systems2) By Radiofrequency Ablators: Monopolar Radiofrequency Ablators; Bipolar Radiofrequency Ablators
3) By Microwave Ablators: Microwave Ablation Systems
4) By Ultrasound Ablators: High-Intensity Focused Ultrasound (HIFU) Systems
5) By Electric Ablators: Electrosurgical Ablators
6) By Hydrothermal Ablators: Steam Ablation Systems
7) By Cryoablators: Cryoablation Systems
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Johnson & Johnson; Abbott Laboratories; AngioDynamics Inc; CONMED Corporation; Olympus Corporation; Smith & Nephew plc; AtriCure Inc; Stryker Corporation; Biotronik SE & Co KG; BTG plc; Terumo Corporation; Varian Medical Systems Inc; Hologic Inc; Accuray Inc; Bard Inc; Elekta AB; Misonix Inc; Japan Lifeline Co Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ablation Devices market report include:- Medtronic plc
- Boston Scientific Corporation
- Johnson & Johnson
- Abbott Laboratories
- AngioDynamics Inc
- CONMED Corporation
- Olympus Corporation
- Smith & Nephew plc
- AtriCure Inc
- Stryker Corporation
- Biotronik SE & Co KG
- BTG plc
- Terumo Corporation
- Varian Medical Systems Inc
- Hologic Inc
- Accuray Inc
- Bard Inc
- Elekta AB
- Misonix Inc
- Japan Lifeline Co Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.12 Billion |
| Forecasted Market Value ( USD | $ 14.02 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
